There were 1,666 press releases posted in the last 24 hours and 413,141 in the last 365 days.

NAAT Technique Is A Popular Method Of Testing In The Blood Transfusion Diagnostics Industry

Blood Transfusion Diagnostics Market Report 2021: COVID-19 Growth And Change To 2030

Blood Transfusion Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030

The Business Research Company’s Blood Transfusion Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON , UK, April 14, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

The growing demand for advanced diagnostic measures and growing prevalence of infectious diseases associated with pathogens such as bacteria & viruses increase the preference for nucleic acid amplification testing (NAAT/NAT) to increase blood safety, improve efficiency and reduce turnaround time of the results. NAT is a technique that helps detect a particular nucleic acid, virus, or bacteria which acts as a pathogen in blood, tissue, or urine. NAT is highly sensitive and specific for viral nucleic acids and amplifies the region of targeted viral DNA and detects them earlier than the other traditional methods and narrows the period of infectious diseases. For example, XCRP Diagnostic Inc. and Luminex Corporations entered into a licensing agreement of XCR Diagnostic's Xtreme Chain Reaction Nucleic Acid Amplification Technology. In this deal, Luminex got the exclusive rights to use the XCR Diagnostic's NAAT technology for their future molecular diagnostic portfolio.

The blood transfusion diagnostics market is highly regulated by governing bodies such as USFDA (the USA Food and Drug Administration), and Medicines and Healthcare products Agency (MHRA). For instance, the manufacturers and service providers in the USA must comply with the Center for Biologics Evaluation and Research (CBER) Regulations that have been published in the first chapter title 21 of Code of Federal Regulations (CFR). Part 600 of CFR 21 primarily focuses on the established standards like retention samples conditions, temperature to be maintained during shipment, sterilization of equipment's and role and duties of the inspector to inspect the laboratories. The regulation also allows the manufacturer to report any kind of deviation of their product from their intended purpose.

The blood transfusion diagnostics market covered in this report is segmented by type into instruments and kits, reagents, others. The blood transfusion diagnostics market is also segmented by end user into hospitals, diagnostic laboratories, blood banks, plasma fractionation companies; by technology into western blot, ELISA, nucleic acid amplification, fluorescence assay, rapid test; by application into blood grouping, disease screening.

Read More On The Global Blood Transfusion Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

The global blood transfusion diagnostics market size is expected to grow from $3.82 billion in 2020 to $4.18 billion in 2021 at a compound annual growth rate (CAGR) of 9.4%. The blood transfusion diagnostics market growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The blood transfusion diagnostics market is expected to reach $5.28 billion in 2025 at a CAGR of 6%.

Major players in the blood transfusion diagnostics industry are BAG Health Care GmbH, Grifols, Bio-Rad Laboratories, Inc., Abbott Laboratories and Immucor Inc.

Blood Transfusion Diagnostics Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides blood transfusion diagnostics market overview, forecast blood transfusion diagnostics market size and growth for the whole market, blood transfusion diagnostics market segments, and geographies, blood transfusion diagnostics market trends, blood transfusion diagnostics market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Blood Transfusion Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp

Here Is A List Of Similar Reports By The Business Research Company:

Patient Blood Management Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/patient-blood-management-market-global-report-2020-30-covid-19-growth-and-change

Blood And Blood Components Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Wearable Blood Pressure Monitors Market - By Product (Upper Arm Blood Pressure Monitor, Wrist Blood Pressure Monitor, Finger Blood Pressure Monitor), And By Region, Opportunities And Strategies - Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/wearable-blood-pressure-monitors-market

Anemia And Other Blood Disorder Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn